Product Images Phentermine And Topiramate

This text provides data on percent weight change in adults with obesity or overweight with co-morbidities over a 56-week period in two different studies. It includes information on the impact of different phenitop doses compared to a placebo, with statistical significance highlighted at different time points for both completers and the Intent-to-Treat-Last-Observed-Carried-Forward (ITT-LOCF) group.*

This text provides dosages for Phentermine/Topiramate (PHEN/TOP ER) in different amounts (7.5 mg, 15 mg/92 mg) and includes the note that the plot includes observed data related to this medication.*

This text provides information about different formulations of Phentermine and Topiramate Extended-Release Capsules, including their dosage strengths and color combinations for cap and body. This information can be useful for healthcare professionals and individuals prescribed these medications to ensure correct identification and appropriate use.*

This text provides information about a medication with NDC 66993-780-30, specifically Phentermine Extended-Release capsules. The capsules are purple/purple, with the cap having "VIVUS" printed in white and the body displaying "3.75/23" in white. Each capsule contains Phentermine 3.75 mg (equivalent to 4.67 mg Phentermine Hydrochloride USP). The text also includes storage instructions, warnings about moisture, and a reminder to keep the medication out of reach. For more details on dosage and prescribing information, it suggests referring to the accompanying product literature.*

This is a description of a medication labeled as NDC 66993-781-30, which consists of Phentermine capsules. The capsules are purple and yellow in color, with the purple cap having the text "VVUS" printed in white. They are Extended-Release capsules with each containing Phentermine 7.5 mg. The medication should be stored at room temperature and protected from moisture. For more information on dosage and other prescribing details, one should refer to the accompanying product literature. The medication is distributed by Prasco Laboratories located in Mason, OH, USA.*

This is a description of a medication labeled with NDC 66993-782-30, indicating it's distributed by Prasco. The medication is in capsule form, with the yellow cap labeled "VIVUS" and the yellow body labeled "11.25/69." It contains Phentermine 11.25 mg and is meant for extended-release. The storage instructions advise keeping it at room temperature, away from moisture, and out of reach of children. For detailed dosage and prescribing information, it recommends referring to the accompanying product literature.*

This text provides information about a medication called Phentermine, specifically the Extended-Release capsules with a dosage of 15 mg/92 mg. It includes details on storage, safety precautions, distribution, and the appearance of the capsules. The medication should be stored at room temperature, protected from moisture, and kept out of reach of children. The capsules are described as yellow/white with specific markings on the cap and body. For complete dosage and prescribing information, refer to the accompanying product literature.*